Exercise and Blood Glucose Levels in Patients with Type I Diabetes - a Pilot Study

Medizinische Universität Graz/Endokrinologie und Stoffwechsel0 sitesJanuary 8, 2014

Overview

No summary available.

Registry

who.int

Start Date

January 8, 2014

End Date

TBD

Last Updated

12 years ago

Study Type

Interventional clinical trial of medicinal product

Sex

Male

Sponsor

Medizinische Universität Graz/Endokrinologie und Stoffwechsel

•Subjects must give their signed and dated informed consent before any trial\-related activities. Trial\-related activities are any procedure that would not have been performed during normal management of the subject
•Male subjects with type 1 diabetes with duration \=12 month
•Age \= 18 to \= 35 years, both inclusive
•HbA1c \= 64 mmol/mol
•Fasting C\-peptide negative (\= 0\.3 nmol/l)
•Treatment with intensified insulin therapy or insulin pump therapy
•No diabetic long term complications
•No other physical and/or mental disease
•Are the trial subjects under 18? no
•Number of subjects for this age range:

•Previous participation (randomisation) in this trial
•History of any illness or disease that, in the opinion of the Investigator might confound the results of the trial
•Use of drugs, which may interfere with the interpretation of trial results or are known to cause clinically relevant interference with insulin action, glucose utilisation, or recovery from hypoglycemia
•Current addiction to alcohol or substances of abuse as determined by the investigator
•Known or suspected allergy to trial products or related products
•Any condition that the investigator feels would interfere with the trial participation or evaluation of data
•Testing day inclusion criteria:
•48h before testing no hypoglycemia
•24h before testing no alcohol